- Home
- BRID vs INMB Comparison
BRID vs INMB Comparison
Compare BRID & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRID
- INMB
- Stock Information
- Founded
- BRID 1932
- INMB 2015
- Country
- BRID United States
- INMB United States
- Employees
- BRID N/A
- INMB N/A
- Industry
- BRID Specialty Foods
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- BRID Consumer Staples
- INMB Health Care
- Exchange
- BRID Nasdaq
- INMB Nasdaq
- Market Cap
- BRID 87.3M
- INMB 103.1M
- IPO Year
- BRID N/A
- INMB 2019
- Fundamental
- Price
- BRID $10.41
- INMB $6.45
- Analyst Decision
- BRID
- INMB Strong Buy
- Analyst Count
- BRID 0
- INMB 2
- Target Price
- BRID N/A
- INMB $21.00
- AVG Volume (30 Days)
- BRID 2.3K
- INMB 377.7K
- Earning Date
- BRID 03-07-2025
- INMB 10-31-2024
- Dividend Yield
- BRID N/A
- INMB N/A
- EPS Growth
- BRID N/A
- INMB N/A
- EPS
- BRID N/A
- INMB N/A
- Revenue
- BRID $231,734,000.00
- INMB $42,000.00
- Revenue This Year
- BRID N/A
- INMB N/A
- Revenue Next Year
- BRID N/A
- INMB N/A
- P/E Ratio
- BRID N/A
- INMB N/A
- Revenue Growth
- BRID N/A
- INMB N/A
- 52 Week Low
- BRID $7.77
- INMB $4.32
- 52 Week High
- BRID $14.69
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- BRID 51.47
- INMB 63.48
- Support Level
- BRID $10.20
- INMB $5.82
- Resistance Level
- BRID $10.50
- INMB $6.83
- Average True Range (ATR)
- BRID 0.18
- INMB 0.55
- MACD
- BRID -0.09
- INMB 0.18
- Stochastic Oscillator
- BRID 42.47
- INMB 83.61
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.